Innoviva INVA
NASDAQ INVA
$21.33 -0.02 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Innoviva (INVA) Gross Profit (2011 - 2026)

Innoviva's (INVA) quarterly Gross Profit came in at $75.8 million in Q1 2026, up 3.43% YoY from $73.3 million in Q1 2025, and down 67.31% on a QoQ basis from $232.0 million in Q3 2025.

Analysis

Innoviva (INVA) Gross Profit (2011 - 2026) Analysis & Trends

Innoviva (INVA) has 9 years of Gross Profit data on file, last reported at $75.8 million in Q1 2026.

  • Quarterly Gross Profit rose 3.43% year-over-year to $75.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $464.3 million (up 6.37% YoY) and the FY2025 annual result came in at $307.7 million, up 3.87% from the prior year.
  • Gross Profit declined to $75.8 million in Q1 2026, from $232.0 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $261.9 million in Q3 2022 to a low of -$6.2 million in Q2 2023.
  • A 5-year average of $101.0 million and a median of $75.8 million in 2026 frame the typical range for Gross Profit.
  • Annual changes were most pronounced in 2023 — Gross Profit slumped 249.76% — and 2024, when it surged 24227.13%.
  • Tracing INVA's Gross Profit over 5 years: stood at $261.9 million in 2022, then declined by 14.83% to $223.0 million in 2023, then dropped by 2.22% to $218.1 million in 2024, then rose by 6.38% to $232.0 million in 2025, then sank by 67.31% to $75.8 million in 2026.
  • The last three Gross Profit figures came in at $75.8 million (Q1 2026), $232.0 million (Q3 2025), and $83.1 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Innoviva 1.56 Bn 984.81 Mn 90.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 90.62 Mn
Mar 31, 2026 75.83 Mn
Sep 30, 2025 232.00 Mn
Jun 30, 2025 83.15 Mn
Mar 31, 2025 73.32 Mn
Sep 30, 2024 218.08 Mn
Jun 30, 2024 84.99 Mn
Mar 31, 2024 60.09 Mn
Sep 30, 2023 196.71 Mn
Jun 30, 2023 72.01 Mn
Mar 31, 2023 67.62 Mn
Sep 30, 2022 261.86 Mn
Jun 30, 2022 108.22 Mn
Mar 31, 2022 90.06 Mn
Sep 30, 2021 284.19 Mn
Mar 31, 2014 592,000.00
Mar 31, 2013 1.32 Mn
Dec 31, 2011 5.36 Mn
Sep 30, 2011 6.43 Mn
Jun 30, 2011 5.21 Mn